COVID-19 vaccine product information
Updated 25 March 2026
© Crown copyright 2026
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/covid-19-vaccination-vaccine-product-information-poster/which-covid-19-vaccine
COVID-19 vaccines used in the UK including information on dose, eligible ages, storage, stability and appearance.
Spikevax
| Spikevax LP.8.1 50 micrograms/dose Moderna |
|
|---|---|
| Dose | 0.5ml (50 micrograms) by intramuscular injection |
| Age | From 18 years |
| Number of doses per unit | 5 (vial) |
| Dilution required? | No: ready to use |
| Refrigerated storage | Thawed and unopened: up to 30 days at +2°C to +8°C |
| Room temperature stability | Unopened vials may be stored for up to 24 hours up to +25°C |
| Stability after first puncture [footnote 1] | May be stored between +2°C and +25°C; use within 6 hours |
| Appearance | A white to off-white dispersion |
Comirnaty 30
| Comirnaty 30 LP.8.1 30 micrograms/dose Pfizer BioNTech |
|
|---|---|
| Dose | 0.3ml (30 micrograms) by intramuscular injection |
| Age | 12 to 17 years |
| Number of doses per unit | 1 (prefilled syringe) |
| Dilution required? | No: ready to use |
| Refrigerated storage | 12 months at +2°C to +8°C |
| Room temperature stability | Unopened prefilled syringes may be stored for up to 12 hours at temperatures up to +30°C |
| Stability after first puncture [footnote 1] | N/A |
| Appearance | A white to off-white dispersion |
Comirnaty 10
| Comirnaty 10 LP.8.1 10 micrograms/dose Pfizer BioNTech |
|
|---|---|
| Dose | 0.3ml (10 micrograms) by intramuscular injection |
| Age | 5 to 11 years |
| Number of doses per unit | 1 (vial) |
| Dilution required? | No: ready to use once thawed |
| Refrigerated storage | Thawed and unopened: up to 10 weeks at +2°C to +8°C |
| Room temperature stability | Unopened vials may be stored for up to 12 hours at temperatures up to +30°C |
| Stability after first puncture [footnote 1] | May be stored between +2°C and +30°C; use within 12 hours |
| Appearance |
Prior to mixing: the thawed dispersion may contain white to offwhite opaque amorphous particles After mixing: clear to slightly opalescent dispersion with no particulates visible |
Comirnaty 3
| Comirnaty 3 LP.8.1 3 micrograms/dose Concentrate Pfizer BioNTech |
|
|---|---|
| Dose | 0.3ml (3 micrograms) by intramuscular injection |
| Age | From 6 months to 4 years |
| Number of doses per unit | 3 (vial) |
| Dilution required? | Yes with 1.1ml sodium chloride 0.9% solution for injection |
| Refrigerated storage | Thawed and unopened: up to 10 weeks at +2°C to +8°C |
| Room temperature stability | Unopened vials may be stored for up to 12 hours at temperatures up to +30°C |
| Stability after first puncture [footnote 1] | May be stored between +2°C and +30°C; use within 12 hours |
| Appearance |
Prior to dilution: the thawed dispersion may contain white to offwhite opaque amorphous particles Diluted vaccine: clear to slightly opalescent dispersion with no particulates visible |
Nuvaxovid
| Nuvaxovid JN.1 5 micrograms/dose Sanofi |
|
|---|---|
| Dose | 0.5ml (5 micrograms) by intramuscular injection |
| Age | Follow Green Book and NHS guidance |
| Number of doses per unit | 1 (prefilled syringe) |
| Dilution required? | No: ready to use |
| Refrigerated storage | Up to 9 months at +2°C to +8°C |
| Room temperature stability | Data not available: remove syringes from the vaccine fridge just before use |
| Stability after first puncture [footnote 1] | N/A |
| Appearance | A colourless to slightly yellow, clear to mildly opalescent disperson free from visible particles |
All products except Nuvaxovid contain Polyethylene Glycol (PEG); Nuvaxovid contains Polysorbate 80.
All vaccines should be used in accordance with Green Book and NHS England operational guidance.
Further information on the COVID-19 vaccination programme is available in the COVID-19 Green Book.
Order copies
Printed copies of this poster can be ordered free of charge from Find Public Health Resource using product code 13114587EN001.
Find public health resources
Find this resource on www.gov.uk/publichealthresources where you can view, download or order resources free of charge.
Alternatively, you can get in touch by phone or email.
Please have the product code with you when you contact us.
Email publichealthresources@ukhsa.gov.uk
Contact form https://www.gov.uk/gui...
Telephone: 0300 123 1002
Monday to Friday, 9am to 5:30pm